Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02970539
Title Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kinex Pharmaceuticals Inc
Indications

esophageal cancer

gastroesophageal junction adenocarcinoma

stomach cancer

Therapies

Oraxol + Ramucirumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.